SensiStain™ Anti-ERG Antibody
ERG is found in malignant and benign vascular endothelial tumors, including hemangiomas and Kaposi sarcoma. It is also present in various prostate carcinomas, but absent in breast, colon and urothelium carcinomas. SensiStain Anti-Recombinant ERG Antibody is useful for differentiating prostate carcinoma from non-prostatic epithelial tumors, and for recognizing vascular endothelial neoplasms.
Product Specifications
CAS Number
9007-83-4
Reactivity
Human
Immunogen
Recombinant Protein
Clonality
Monoclonal
Clone
IHC569
Type
Antbodies-IHC
Applications
ELISA, IHC
Purity
Purified
Buffer
Tris Buffer, pH 7.3 - 7.7, with 1% BSA and <0.1% Sodium Azide
Shipping Conditions
Ice Pack
Storage Conditions
This product is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. For extended storage, aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Expiration date is one (1) year from date of receipt.
Fragment
IgG
Specificity
ERG
Applications Notes
1:50-1:200
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400029-100 1x 100 µL
Fibronectin (TV-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040149-500 1x 500 µL
CD106 / VCAM1 (1.4C3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470204-100 1x 100 µL
Complement C4d (C4D204), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040096-100 1x 100 µL
Histone H1 (AE-4), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details